Volume | 9,099 |
|
|||||
News | - | ||||||
Day High | 79.76 | Low High |
|||||
Day Low | 78.46 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
Invesco Pharmaceuticals ETF | PJP | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
79.76 | 78.46 | 79.76 | 79.2084 | 78.64 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
206 | 9,099 | 78.74 | 716,493 | - | 67.75 - 80.65 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:00 | 100 | 79.2084 | USD |
Invesco Pharmaceuticals ETF Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
311.14M | 3.94M | - | 4.61M | 8.3M | 2.11 | 37.48 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Invesco Pharmaceuticals ...
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PJP Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 75.49 | 79.76 | 75.49 | 77.77 | 7,591 | 3.72 | 4.93% |
1 Month | 77.65 | 79.76 | 75.326 | 77.59 | 17,801 | 1.56 | 2.01% |
3 Months | 76.52 | 80.65 | 75.326 | 78.04 | 24,935 | 2.69 | 3.51% |
6 Months | 70.57 | 80.65 | 67.75 | 76.89 | 20,107 | 8.64 | 12.24% |
1 Year | 77.47 | 80.65 | 67.75 | 76.43 | 15,454 | 1.74 | 2.24% |
3 Years | 78.43 | 84.1065 | 67.75 | 77.71 | 17,786 | 0.7784 | 0.99% |
5 Years | 63.32 | 84.1065 | 47.14 | 69.89 | 22,970 | 15.89 | 25.09% |
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified. |